Axinn partners Aziz Burgy and Matt Murphy spoke at ACI's 8th Annual Paragraph IV Disputes Master Symposium, held September 21-22 in Chicago.
On September 21, Aziz spoke on a panel entitled, "Skinny Labeling: The Future of Carveouts and Analyzing the Influence of GSK v. Teva on Competition." Panelists analyzed whether a skinny label alone is enough to preclude induced infringement allegations; reviewed implications of recent decisions for induced infringement; devised strategic considerations of label language for inducement infringement; reviewed the approval of generic drug labeling; and assessed the flurry of follow-on cases in the courts.
On September 22, Matt spoke on a panel entitled, "Revisiting Damages in an At-Risk Launch Scenario: Questions of Remedies and Valuation." Panelists revisited damages in an at-risk launch scenario and explored questions of royalties, lost profits, and exceptions findings; examined grounds for mitigation; and considered the practical consequences of the Supreme Court's WesternGeco decision on Hatch-Waxman damages awards.
Click here for more information.